These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange]. Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104 [TBL] [Abstract][Full Text] [Related]
8. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Scully M; Starke R; Lee R; Mackie I; Machin S; Cohen H Blood Coagul Fibrinolysis; 2006 Sep; 17(6):459-63. PubMed ID: 16905949 [TBL] [Abstract][Full Text] [Related]
9. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. Clark WF; Rock G; Barth D; Arnold DM; Webert KE; Yenson PR; Kelton JG; Li L; Foley SR; Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259 [TBL] [Abstract][Full Text] [Related]
10. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection. Mak SK; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Tong GM; Wong PN; Ma ES; Wong AK Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376 [TBL] [Abstract][Full Text] [Related]
13. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura. Patriquin CJ; Thomas MR; Dutt T; McGuckin S; Blombery PA; Cranfield T; Westwood JP; Scully M Br J Haematol; 2016 Jun; 173(5):779-85. PubMed ID: 27009919 [TBL] [Abstract][Full Text] [Related]
14. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor. Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review. Harambat J; Lamireau D; Delmas Y; Ryman A; Llanas B; Brissaud O Pediatr Crit Care Med; 2011 Mar; 12(2):e90-3. PubMed ID: 20625343 [TBL] [Abstract][Full Text] [Related]
16. A case series of atypical presentations of thrombotic thrombocytopenic purpura. Imanirad I; Rajasekhar A; Zumberg M J Clin Apher; 2012; 27(4):221-6. PubMed ID: 22467376 [TBL] [Abstract][Full Text] [Related]
17. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Uhl L; Kiss JE; Malynn E; Terrell DR; Vesely SK; George JN Transfusion; 2017 Oct; 57(10):2532-2538. PubMed ID: 28671324 [No Abstract] [Full Text] [Related]
18. Rituximab for thrombotic thrombocytopenic purpura. Kivity S; Agmon-Levin N Isr Med Assoc J; 2011 Jul; 13(7):436-7. PubMed ID: 21838188 [No Abstract] [Full Text] [Related]
19. Ofatumumab for TTP in a Patient with Anaphylaxis Associated with Rituximab. Crowley MP; McDonald V; Scully M N Engl J Med; 2018 Jan; 378(1):92-93. PubMed ID: 29298144 [No Abstract] [Full Text] [Related]
20. Serial ADAMTS13 measurements during initial plasma exchange therapy guide decisions for management of unresponsive thrombotic thrombocytopenic purpura. van der Veen BS; Besseling R; Hoogendoorn M Transfusion; 2015 Oct; 55(10):2511-5. PubMed ID: 26308736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]